USFDA Chief Apologizes For Overstating Benefits of Convalescent Plasma Therapy
Following backlash from critics, FDA chief Stephen Hahn apologized for his remarks that were in agreement with the US President Donald Trump’s claim that convalescent plasma is a powerful therapy for COVID-19. The race against the clock to find a safe and efficacious treatment option against COVID-19 has been ongoing for the last 9 months. The difficulty lies not only in finding the appropriate medical intervention
GO Prime with only $1.49 now
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115